India’s highest court has rejected a drug firm’s attempt to patent a cancer treatment in a landmark decision that health activists said ensures poor patients worldwide will continue to get cheap versions of lifesaving medicines.

Activists say cheaply made Indian generics are a lifesaver for millions of patients in poor countries but drugmakers are intent on protecting their patents. Nirmala George reports from New Delhi